openPR Logo
Press release

Infantile and Juvenile-onset Hypophosphatasia Treatment Market to Undertake Strapping Growth by 2025

03-31-2018 09:07 AM CET | Health & Medicine

Press release from: Persistence Market Research

Infantile and Juvenile-onset Hypophosphatasia Treatment

The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short stature and weak bones with loss of mobility, and may also result in premature death. According to U.S. Food and Drug Administration, it is estimated that in about 100,000 newborns, one suffers severe hypophosphatasia. The mildest form of hypophosphatasia is called odontohypophosphatasia and is affects teeth. Infantile and perinatal hypophosphatasia is an autosomal recessive disease. Hypophosphatasia is an ultra-rare disease affecting < 20 people per million and it effects people of all ages as it is caused due to deficiency of an enzyme known as tissue non-specific alkaline phosphatase (TNSALP), which leads to high level of tissue non-specific alkaline phosphatase (TNSALP) substrates, including inorganic pyrophosphate. The adult form of this disease and odontohypophosphatasia is an autosomal recessive or autosomal dominant disease.

Request Report for Table of Contents @ https://www.persistencemarketresearch.com/toc/22495

Treatment and management of hypophosphatasia (HPP) is symptomatic and supportive, it aims at addressing symptoms of disease such as thiazide diuretics for hypercalcemia, ventilator support, occupational therapy and surgery for bone fractures. In October 2015, the enzyme replacement therapy has been recently approved for the treatment of abnormal bone structure in people with onset hypophosphatasia (HPP). The HPP community are helping to bring programs that will bring new and treatment options to people with rare diseases. Currently, clinical trials are conducted, wherein a large number of organization are actively participating in several research programs to develop novel therapies for infantile and juvenile-onset hypophosphatasia treatment.

Introduction of several novel therapy, breakthrough therapy designation, orphan drug designation for rare diseases, financial incentives and grants by the government, clinical studies on safety and efficacy of products, is expected to be the biggest hit in the global infantile and juvenile-onset hypophosphatasia treatment over the forecast period. Gaps in making hypophosphatasia (HPP) health priority, patients’ non-adherence to therapy regime, high therapy cost, less number of approved therapies, failure in clinical trial at the late phase are some of the factors restraining the infantile and juvenile-onset hypophosphatasia treatment market.

Global Infantile and Juvenile-onset Hypophosphatasia Treatment market is segmented by treatment type, and end user. Based on the treatment type, global Infantile and Juvenile-onset Hypophosphatasia treatment market is segmented as supportive care and enzyme replacement therapy. On the basis of end user, the global infantile and juvenile-onset hypophosphatasia treatment market is segmented into hospital, clinics, clinical research organizations and others. Rise in patient population of hypophosphatasia, increased awareness and new product/therapy launch is said to drive the global Infantile and Juvenile-onset hypophosphatasia treatment market during the forecast period. Whereas inadequate access to health care, cost and availability of essential medicines and lack of standardized tools for diagnosis and treatment will hamper the growth of global infantile and juvenile-onset hypophosphatasia treatment market.

By Geography, the global Infantile and juvenile-onset hypophosphatasia treatment market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to lead the global Infantile and Juvenile-onset Hypophosphatasia Treatment market due to rise in cases of hypophosphatasia in United States, Europe market is also projected to experience high growth in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as rising standard of living, lifestyle changes, rise in research and development, government initiatives, drug designations such as breakthrough therapy, Orphan drug designation by FDA helps company to work collaboratively with sponsors to expedite the drug development process.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/22495

Some of the major players in global Infantile and Juvenile-onset Hypophosphatasia Treatment market are Alexion Pharmaceuticals Inc., Novartis A.G, and Others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infantile and Juvenile-onset Hypophosphatasia Treatment Market to Undertake Strapping Growth by 2025 here

News-ID: 999493 • Views:

More Releases from Persistence Market Research

Riding Boots Market Expanding Rapidly Through 2030, PMR Report
Riding Boots Market Expanding Rapidly Through 2030, PMR Report
Introduction The global riding boots market has gained substantial traction over recent years, driven by increased interest in equestrian sports, leisure riding activities, and the growing awareness of safety and comfort during horse riding. Riding boots, designed for both functionality and style, cater to a wide range of consumers, from professional equestrians to casual riders. With advancements in material technology and consumer preferences for eco-friendly and high-performance products, the riding boots
Aircraft Seats Market Forecast to Achieve US$ 7.83 Billion by 2032
Aircraft Seats Market Forecast to Achieve US$ 7.83 Billion by 2032
Introduction The global aircraft seats market is a key segment within the aviation industry, directly tied to the growing demand for air travel and enhanced passenger comfort. Aircraft seats are an essential component of aircraft interiors, significantly influencing the passenger experience. As air travel continues to rebound following pandemic-related disruptions, the demand for advanced, lightweight, and comfortable aircraft seats is escalating. This report offers a comprehensive analysis of the aircraft seats
Dog Collars, Leashes & Harnesses Market to Hit US$9.51 Bn by 2030 at 8.2% CAGR
Dog Collars, Leashes & Harnesses Market to Hit US$9.51 Bn by 2030 at 8.2% CAGR
Introduction The dog collars, leashes, and harnesses market is witnessing significant growth as pet ownership trends surge globally. Pet owners are prioritizing safety, comfort, and style for their furry companions, driving innovation in this segment. This report delves into the market's key growth determinants, barriers, opportunities, and regional trends, offering insights into its trajectory through 2030. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐏𝐃𝐅-https://www.persistencemarketresearch.com/samples/33850 Market Overview The global dog collars, leashes & harnesses market is forecasted to expand
Fire-Resistant Cable Industry on Track to Reach US$ 2,486.7 Million by 2030
Fire-Resistant Cable Industry on Track to Reach US$ 2,486.7 Million by 2030
Introduction Fire-resistant cables are essential components in modern infrastructure, ensuring safety and reliability in case of fire emergencies. These cables are designed to withstand high temperatures and maintain functionality during a fire, which makes them crucial in industries such as construction, energy, automotive, and telecommunications. As fire safety standards become more stringent globally, the demand for fire-resistant cables is on the rise. This report provides an overview of the global fire-resistant

All 5 Releases


More Releases for Infantile

Infantile Spasms Therapeutics Market Analysis by Key Players & Industry Size 202 …
According to a new report published by Allied Market Research, titled, " Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid) and by Route of Administration (Oral and Parenteral) - Global Opportunity Analysis and Industry Forecast, 2021-2028" The Global market size of Immunomodulators is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from
Infantile Spasms Therapeutics Market to Boost Revenue with Massive Growth
Global Infantile Spasms Therapeutics Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid)
Global Infantile Spasms Therapeutics Market 2018:- Mallinckrodt, H. Lundbeck, In …
Market Research Store Exposed a new deep Industry research report focuses on Infantile Spasms Therapeutics Market, delivers detailed analysis of market and future prospects of Infantile Spasms Therapeutics market. The critical and significant data in the study makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis by the industry professionals. The Infantile Spasms Therapeutics Market report provides the complete analysis of Infantile Spasms
Infantile Spasms Therapeutics Market Scope and Opportunities Analysis 2017 – 2 …
Infantile spasms therapeutics are used for the treatment of seizures or an epilepsy syndrome in young children, usually aged one year or below. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Primary treatments for infantile spams include steroid therapy and an anti-seizure medicine called Sabril. Infantile spasms are also known as the West syndrome, as the disease was
Global Infantile Spasms Therapeutics Market 2017-2021
Qyresearchreports include new market research report Global Infantile Spasms Therapeutics Market Professional Survey Report 2017 to its huge collection of research reports. In a highly dynamic global market for Infantile Spasms Therapeutics, companies need to constantly evolve to stay ahead of the curve. To do so, they need accurate information on the market. The recent report endeavors to help them achieve their growth targets by offering crucial information on the global
Malignant Infantile Osteopetrosis Market to See Incredible Growth During 2027
Malignant Infantile osteopetrosis is also called as infantile autosomal recessive osteopetrosis. It is one of the rare skeletal dysplasia that is characterized using a radiographic pattern which shows increased bone density with involvement of the medullary portion. This type of disease typically manifests in infancy. Diagnosis of Malignant Infantile Osteopetrosis is based on radiographic evaluation and clinical evaluation, that is further confirmed using gene analysis technique if required. Due to